1. Dave, M, et al. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis. 2014; 20(1):196–212.
2. Pariente, B, et al. Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases. Aliment Pharmacol Ther. 2014; 40(4):338–353.
3. Curkovic, I, et al. Risks of inflammatory bowel disease treatment with glucocorticosteroids and aminosalicylates. Dig Dis. 2013; 31(3–4):368–373.
4. Florescu, DF, et al. Opportunistic viral infections in intestinal transplantation. Expert Rev Anti Infect Ther. 2013; 11(4):367–381.
5. Tonolini, M, et al. Acute HIV-related gastrointestinal disorders and complications in the antiretroviral era: spectrum of cross-sectional imaging findings. Abdom Imaging. 2013; 38(5):994–1004.
6. Werneck-Silva, AL, et al. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy. J Gastroenterol Hepatol. 2009; 24(1):135–139.
7. Hampton, DD, et al. Inflammatory bowel disease following solid organ transplantation. Clin Immunol. 2008; 128(3):287–293.
8. Ishida, T, et al. The management of gastrointestinal infections caused by cytomegalovirus. J Gastroenterol. 2003; 38(7):712–713.
9. Koh, DM, et al. Abdominal computed tomographic findings of Mycobacterium tuberculosis and Mycobacterium avium intracellulare infection in HIV seropositive patients. Can Assoc Radiol J. 2003; 54(1):45–50.
10. Brantsaeter, AB, et al. CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo. Scand J Infect Dis. 2002; 34(1):50–55.
11. Hunter, PR, et al. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 2002; 15(1):145–154.
12. Masur, H, et al. Guidelines for preventing opportunistic infections among HIV-infected persons—2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med. 2002; 137(5 Pt 2):435–478.
13. Oldfield, EC, 3rd. Evaluation of chronic diarrhea in patients with human immunodeficiency virus infection. Rev Gastroenterol Disord. 2002; 2(4):176–188.
14. Ukarapol, N, et al. Cytomegalovirus-associated manifestations involving the digestive tract in children with human immunodeficiency virus infection. J Pediatr Gastroenterol Nutr. 2002; 35(5):669–673.
15. von Reyn, CF, et al. Sources of disseminated Mycobacterium avium infection in AIDS. J Infect. 2002; 44(3):166–170.
16. Huh, JJ, et al. Mycobacterium avium complex peritonitis in an AIDS patient. Scand J Infect Dis. 2001; 33(12):936–938.
17. Pollok, RC. Viruses causing diarrhoea in AIDS. Novartis Found Symp. 2001; 238:276–283. [discussion 283-8].
18. Chamberlain, RS, et al. Ileal perforation caused by cytomegalovirus infection in a critically ill adult. J Clin Gastroenterol. 2000; 30(4):432–435.
19. Clemente, CM, et al. Gastric cryptosporidiosis as a clue for the diagnosis of the acquired immunodeficiency syndrome. Arq Gastroenterol. 2000; 37(3):180–182.
20. Wallace, MR, et al. Gastrointestinal manifestations of HIV infection. Curr Gastroenterol Rep. 2000; 2(4):283–293.
21. Drew, WL, et al. Cytomegalovirus: disease syndromes and treatment. Curr Clin Top Infect Dis. 1999; 19:16–29.
22. Lumadue, JA, et al. A clinicopathologic analysis of AIDS-related cryptosporidiosis. AIDS. 1998; 12(18):2459–2466.
23. Manabe, YC, et al. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis. 1998; 27(3):536–542.
24. Rossi, P, et al. Gastric involvement in AIDS associated cryptosporidiosis. Gut. 1998; 43(4):476–477.